Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)

NCT06049212

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Aichi Cancer Center ( Site 0006) Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East ( Site 0002) Kashiwa, Chiba, Japan
  • National Hospital Organization Shikoku Cancer Center ( Site 0008) Matsuyama, Ehime, Japan
  • Kanagawa Cancer Center ( Site 0004) Yokohama, Kanagawa, Japan
View Trial Details
Active, Not Recruiting

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

NCT06082960

Conditions
Solid Tumors
Locations
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • NEXT Oncology San Antonio, Texas, United States
  • South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

NCT06818812

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • Sarah Cannon Research Institue At Healthone Denver, Colorado, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Active, Not Recruiting

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

NCT02503423

Conditions
Carcinoma, Carcinoma, Squamous Cell, Female Urogenital Diseases, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease

NCT03347318

Conditions
Solid Tumors
Locations
  • Ospedale Regionale Umberto Parini Aosta, Italy
  • Policlinico S.Orsola Malpighi Bologna, Italy
  • Istituto Di Candiolo - Fondazione Del Piemonte Per L'Oncologia (FPO-Irccs) Candiolo, Italy
  • Azienda Ospedaliero-Universitaria Careggi Genova, Italy
View all 15 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors

NCT03832569

Conditions
Disease Attributes, Disease Progression, Identified by NGS, PCR or IHC, +4 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, Not Recruiting

Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors

NCT03313778

Conditions
Solid Tumors
Locations
  • Angeles Clinic and Research Institute Los Angeles, California, United States
  • The George Washington Cancer Center Washington D.C., District of Columbia, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 20 locations
View Trial Details

Related conditions